Cosmetic cross-reference

Potassium Nitrate

CAS 7757-79-1

Potassium Nitrate (CAS 7757-79-1) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 19 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral / FAERS
Adverse signals
19
SOURCE IUPHAR / PharmGKB
PubMed IDs
0
SOURCE ChEMBL 36 B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Potassium Nitrate
CAS Number
7757-79-1
UNII
RU45X2JN0Z
InChIKey
FGIUAXJPYTZDNR-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1644029
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
withdrawn flag
SOURCE ChEMBL 36 B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1644029 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 2023 / FAERS disproportionality 19 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Respiratory tract infection bacterial 25 103.728 10060693
Respiratory tract infection viral 26 87.447 10062106
Cytokine release syndrome 43 82.466 10052015
Fibrin D dimer increased 22 56.951 10016581
Stoma site discharge 14 46.723 10075512
Stoma site erythema 13 45.811 10074514
On and off phenomenon 14 40.692 10030312
Respiratory tract infection 30 34.076 10062352
Fibroma 9 32.842 10016629
Stoma site irritation 6 25.925 10059072
Bradykinesia 12 24.543 10006100
Freezing phenomenon 8 21.799 10060904
Tension 9 20.34 10043268
Platelet count decreased 45 18.78 10035528
Stoma site pain 6 17.784 10057843
Stoma site haemorrhage 6 16.753 10074508
Stoma site inflammation 5 16.737 10065669
Haemoglobin decreased 46 16.424 10018884
Hypoaesthesia eye 4 15.973 10020939

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE RxNorm drug names 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
POTASSIUM NITRATE 34316 SU MTHSPL
Potassium Nitrate 34316 SU MTHSPL
potassium nitrate 34316 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Potassium Nitrate used for in pharmaceutical contexts?

Potassium Nitrate (CAS 7757-79-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Potassium Nitrate?

Potassium Nitrate has 19 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Respiratory tract infection bacterial, Respiratory tract infection viral, Cytokine release syndrome, Fibrin D dimer increased, Stoma site discharge. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Potassium Nitrate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Potassium Nitrate with EU status "permitted".

What clinical phase is Potassium Nitrate in?

Potassium Nitrate is rendered with ChEMBL max phase 4 (approved).